Canaccord Genuity Maintains Hold on Veracyte, Raises Price Target to $42
Veracyte, Inc.
Veracyte, Inc. VCYT | 0.00 |
Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:
VCYT) with a Hold and raises the price target from $40 to $42.